YONKERS, NY -- (Marketwired) -- 12/04/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue ReadingTag: contrafect
ContraFect Submits Complete Response to IND Clinical Hold for CF-301
YONKERS, NY -- (Marketwired) -- 12/02/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue ReadingContraFect Corporation Announces Third Quarter 2014 Results
YONKERS, NY -- (Marketwired) -- 11/14/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue ReadingContraFect and National Institute for Viral Disease Control and Prevention, China CDC Sign Agreement to Collaborate on Universal Influenza Treatment
YONKERS, NY -- (Marketwired) -- 10/09/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue ReadingContraFect Corporation to Present at the 13th Annual BIO Investor Forum
YONKERS, NY -- (Marketwired) -- 09/30/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue ReadingContraFect Corporation Expands Senior Management Team
Hires Natalie Bogdanos as General Counsel
Continue ReadingContraFect Corporation to Present at BioCentury–s 21st Annual NewsMakers in the Biotech Industry Conference
YONKERS, NEW YORK -- (Marketwired) -- 09/19/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology…
Continue ReadingContraFect Corporation–s Universal Influenza Treatment Receives SBIR Funding
YONKERS, NY -- (Marketwired) -- 09/16/14 -- (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company…
Continue ReadingContraFect Announces Management Team Changes
Office of the Chief Executive With Julia P. Gregory, Newly Appointed Chief Executive Officer, and Sol…
Continue ReadingContraFect Corporation to Present at 12th Annual BIO Investor Forum
Bio Investor Forum to Be Held October 8-9 in San Francisco, Calif.
Continue Reading